ID

33367

Descrizione

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Keywords

versioni (2)
  1. 06/11/18 06/11/18 -
  2. 06/12/18 06/12/18 -
Titolare del copyright

GSK group of companies

Caricato su

6 dicembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Inglese

Study conclusion

1 moduli  
  1. StudyEvent: ODM
    1. Study conclusion
Study conclusion details
Descrizione

Study conclusion details

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Date of subject completion or withdrawal
Descrizione

Date of subject completion or withdrawal

Tipo di dati

date

Alias
UMLS CUI [1]
C2983670
Was the subject withdrawn from the study?
Descrizione

Was the subject withdrawn from the study?

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0422727
If YES, complete primary reason for withdrawal
Descrizione

If YES, complete primary reason for withdrawal

Alias
UMLS CUI-1
C0422727
UMLS CUI-2
C0392360
1. Adverse event
Descrizione

record details on AE or SAE forms as appropriate)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248
2. Lack of efficacy
Descrizione

Check all that apply. If none, select "No Subreasons"

Tipo di dati

text

Alias
UMLS CUI [1]
C0235828
3. Protocol Deviation
Descrizione

Check all that apply. If none, select "No Subreasons"

Tipo di dati

text

Alias
UMLS CUI [1]
C1705236
4. Subject reached protocol defined stopping criteria
Descrizione

4. Subject reached protocol defined stopping criteria

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2746065
UMLS CUI [1,2]
C0243161
5. Study closed/terminated
Descrizione

5. Study closed/terminated

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348570
6. Lost to Follow-Up
Descrizione

6. Lost to Follow-Up

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1302313
7. Investigator discretion, specify
Descrizione

Select this reason if none of the other primary reasons are appropriate

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C0022423
UMLS CUI [1,3]
C2348235
8. Withdrew consent, specify
Descrizione

Select this reason if none of the other primary reasons are appropriate

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2348235
Ritorna all'inizio della pagina

Similar models

Study conclusion

1 moduli
  1. StudyEvent: ODM
    1. Study conclusion
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study conclusion details
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1])
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item Group
If YES, complete primary reason for withdrawal
C0422727 (UMLS CUI-1)
C0392360 (UMLS CUI-2)
1. Adverse event
Item
1. Adverse event
boolean
C0877248 (UMLS CUI [1])
Item
2. Lack of efficacy
text
C0235828 (UMLS CUI [1])
2. Lack of efficacy
Code List
2. Lack of efficacy
CL Item
No subreasons (1)
CL Item
Exacerbation (2)
Item
3. Protocol Deviation
text
C1705236 (UMLS CUI [1])
3. Protocol Deviation
Code List
3. Protocol Deviation
CL Item
No subreasons (1)
CL Item
Pregnancy (2)
CL Item
Lack of adherence (3)
CL Item
Prohibited medication use (4)
Item
4. Subject reached protocol defined stopping criteria
text
C2746065 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Subject reached protocol defined stopping criteria
Code List
4. Subject reached protocol defined stopping criteria
CL Item
Yes (1)
CL Item
No (2)
CL Item
Liver function test abnormality (3)
5. Study closed/terminated
Item
5. Study closed/terminated
boolean
C2348570 (UMLS CUI [1])
6. Lost to Follow-Up
Item
6. Lost to Follow-Up
boolean
C1302313 (UMLS CUI [1])
7. Investigator discretion, specify
Item
7. Investigator discretion, specify
text
C0008961 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
8. Withdrew consent, specify
Item
8. Withdrew consent, specify
text
C1707492 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial